Vision
Hans Group will provide innovative top-class medical equipment
and biomedical supplies until a patient is fully satisfied.
and biomedical supplies until a patient is fully satisfied.
No. 1 Global
No. 1 in the world
(artificial breast implants, lifting suture)
(artificial breast implants, lifting suture)
100 Countries
Exports to more than 100 countries
(R&D investment in the field of new medical treatments and technology)
(R&D investment in the field of new medical treatments and technology)
500 Billion
Achieved the sales of 500 billion KRW
(growth rate gradually increasing)
(growth rate gradually increasing)
Hans Achievements
Approved by the U.S. FDA, MFDS, CE, etc. for its excellent technology and reliable safety
|
Make
Innovations |
1999 - 2002
Established Hans Biomed Co. Ltd.
Selected as "World Top-Class Product Company" Constructed a tissue engineering research lab |
2003 - 2005
Registered human tissue implants to FDA
Acquired permission for establishing Korea's first human tissue bank from MFDS |
|---|---|---|
|
2008 - 2009
Artificial breast approved by CE
Listed on KOSDAQ, the first in the industry |
2012
Demineralized Bone Matrix (DBM) approved by the U.S. FDA 510K
|
|
Steady
Development |
2013 - 2015
Extended Daejeon Tissue Engineering Research Center
MINT LIFT approved by MFDS MINT LIFT approved by the U.S. FDA Artificial breast by MFDS |
2015 - 2019
BellaGel Micro approved in Korea
The smart factory for artificial breasts in the world Artificial breasts approved by CNMPA DBM approved by CNMPA MINT LIFT approved by CE Embolic material for vascular disease treatment approved in Korea |
|---|---|---|
|
2020 - 2022
Preclinical test of stem cell project for diabetes treatment approved
Preclinical test of embolic material for liver cancer treatment approved |
||
-
product
- Biologics
- Medical Device
-
recruit
- Job Opening
- Application
- HR System